General Studies 2021 GS Paper III 15 marks 250 words Compulsory Explain

Q15

What are the research and developmental achievements in applied biotechnology? How will these achievements help to uplift the poorer sections of the society? (Answer in 250 words)

हिंदी में प्रश्न पढ़ें

अनुप्रयुक्त जैव-प्रौद्योगिकी में शोध तथा विकास-संबंधी उपलब्धियाँ क्या हैं ? ये उपलब्धियाँ समाज के निर्धन वर्गों के उत्थान में किस प्रकार सहायक होंगी ? (250 शब्दों में उत्तर दीजिए)

Evaluate your answer to this question → See all 2021 General Studies questions

Directive word: Explain

This question asks you to explain. The directive word signals the depth of analysis expected, the structure of your answer, and the weight of evidence you must bring.

See our UPSC directive words guide for a full breakdown of how to respond to each command word.

How this answer will be evaluated

Approach

Explain requires a clear exposition of R&D achievements in applied biotechnology followed by their socio-economic linkages to poverty alleviation. Structure as: brief introduction defining applied biotechnology → two balanced sections on achievements (GM crops, biofertilizers, biopharma, biofuels) and poverty upliftment mechanisms (income security, health access, employment) → conclusion with forward-looking synthesis on inclusive innovation.

Key points expected

Green Revolution 2.0 achievements: Bt cotton, Bt brinjal, GM mustard, and drought-resistant crop varieties developed by ICAR and private sector
Healthcare biotechnology: Indigenous vaccine development (Covaxin, Rotavac), insulin production, and affordable diagnostics reducing disease burden on poor
Biofertilizers and biopesticides reducing input costs for small farmers; biofuel initiatives (2G ethanol from agricultural waste) creating rural employment
Mechanisms of poverty upliftment: enhanced farm productivity → income security; reduced medical expenditure → savings; decentralized biotech industries → rural employment generation
Challenges and limitations: biosafety concerns, IPR issues, access inequities, need for regulatory strengthening and public sector investment
Way forward: DBT's BioE3 policy, Mission on Bioeconomy, and need for participatory technology assessment ensuring pro-poor orientation

Evaluation rubric

Dimension	Weight	Max marks	Excellent	Average	Poor
Demand-directive understanding	20%	3	Clearly distinguishes between basic and applied biotechnology; addresses both parts of the question (achievements AND poverty linkage) with explicit causal connections rather than listing them separately	Covers both parts but treats them as disconnected sections; conflates basic and applied research; superficial linkage between technology and social impact	Misses one part entirely (only achievements or only poverty aspect); confuses biotechnology with general S&T; no understanding of 'applied' specificity
Content depth & accuracy	20%	3	Precise coverage across all three sectors (agriculture, health, industrial) with accurate names of institutions (DBT, ICAR, NIPER), policies (BioE3, National Biotechnology Development Strategy), and technical specifics	Broad coverage but generic descriptions; minor factual errors in institutional names or policy timelines; limited sectoral spread (focuses heavily on agriculture alone)	Vague generalizations without sectoral specificity; significant factual errors; confused with information technology or generic medical science
Structure & flow	20%	3	Logical progression from achievements to poverty mechanisms with integrated analysis; effective use of subheadings; smooth transitions showing how specific technologies translate to specific welfare outcomes	Clear but mechanical structure with achievements in first half and poverty in second; some repetition; adequate paragraphing but weak integrative logic	Disorganized or haphazard arrangement; no clear demarcation between the two question components; abrupt jumps between unrelated points
Examples / case-law / data	20%	3	Specific Indian examples: Bt cotton adoption data (95% coverage), Covaxin development, 2G ethanol plants in Punjab/Haryana, biofortified crops (Golden Rice trials); mentions DBT's BioE3 policy and Mission Bioeconomy targets	Generic examples (Bt crops without specificity) or foreign examples dominating; mentions institutions without concrete achievements; no quantitative data	No Indian examples; relies entirely on foreign cases (Monsanto, Pfizer) without Indian adaptation; factually incorrect examples or no examples at all
Conclusion & analytical edge	20%	3	Synthesizes with critical insight: acknowledges technology-access paradox, suggests regulatory-social balance, and proposes actionable measures (farmer producer organizations for biotech dissemination, public-private partnerships for affordability); ends with vision of inclusive bioeconomy	Summary restatement without new insight; generic optimism about biotechnology; no critical engagement with limitations or forward-looking policy suggestions	No conclusion or abrupt ending; uncritical techno-optimism ignoring biosafety, equity, or sustainability concerns; irrelevant moralizing

Practice this exact question

Write your answer, then get a detailed evaluation from our AI trained on UPSC's answer-writing standards. Free first evaluation — no signup needed to start.

Evaluate my answer →